Financhill
Back

AbbVie 10K Form

Sell
40

ABBV
AbbVie

Last Price:
162.32
Seasonality Move:
3.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $54.32B
Cash Flow: $4.55B
Price / Cash Flow: 13.05
Annual Sales: $5.87
Price / Book: 27.67

Profitability

EPS (TTM): 2.73000
Net Income (TTM): $4.86B
Gross Margin: $33.9B
Return on Equity: 36.83%
Return on Assets: 3.58%

AbbVie Earnings Forecast

Key AbbVie Financial Ratios

  • The Gross Profit Margin over the past 15 years for ABBV is 62.42%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 23.70% of Gross Profit Margin.
  • The Research & Development expenses have been 14.13% of Revenue.
  • The Interest Expense is 45.73% of Operating Income.
  • The Net Earning history of ABBV is 8.95% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

AbbVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvieinvestor.com

Debt

Debt-to-Equity Ratio: 5.73
Current Ratio: 0.87
Quick Ratio: 0.63

Price-to-Earnings

Trailing P/E Ratio: 59.66
Forward P/E Ratio: 13.36

ABBV Technical Analysis vs Fundamental Analysis

Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy or a Sell?

  • AbbVie stock is rated a Sell
    The current AbbVie [ABBV] share price is $162.28. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.